Latest news for Sonder Holdings (NASDAQ:SONDW) Stock

Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests.

Sonder Holdings Inc

WIIM

Nokia shares are trading lower after the company reported mixed Q2 financial results.

NKGN

NKGen Biotech shares are trading higher after the company announced it will present new SNK01 biomarker data at the Alzheimer's Association International Conference.

During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments">high dividend payout</a>. 
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.
<h3 class="wp-block-heading">Dow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>)</h3>
<ul>
<li>Dividend Yield: 5.05%</li>
<li>Mizuho analyst John Roberts maintained a Neutral rating and increased the price target from $55 to $62 on April 26. This analyst has an accuracy rate of 77%.</li>
<li>JP Morgan analyst Jeffrey Zekauskas upgraded the stock from Neutral to Overweight and boosted the price target from $55 to $61 on April 26. This analyst has an accuracy rate of 70%.</li>
<li>Recent News: On June 20, , Dow signed an agreement to acquire Circulus, a leading recycler of plastic waste into post-consumer resin.</li>
<li><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1">Benzinga Pro's real-time newsfeed</a> alerted to latest DOW news</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="685" height="716" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052217/Screenshot-2024-07-18-at-2.52.06-PM.png" alt="" class="wp-image-442560" style="width:312px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052217/Screenshot-2024-07-18-at-2.52.06-PM.png 685w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052217/Screenshot-2024-07-18-at-2.52.06-PM-287x300.png 287w" sizes="(max-width: 685px) 100vw, 685px" /></a></figure>
<h3 class="wp-block-heading">Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>)</h3>
<ul>
<li>Dividend Yield: 4.22%</li>
<li>Wells Fargo analyst Michael Sison maintained an Overweight rating and cut the price target from $32 to $28 on July 11. This analyst has an accuracy rate of 71%.</li>
<li>JP Morgan analyst Jeffrey Zekauskasupgraded the stock from Underweight to Overweight and boosted the price target from $22 to $27 on June 7. This analyst has an accuracy rate of 70%.</li>
<li>Recent News: Huntsman is scheduled to hold a conference call on Tuesday, Aug. 6, 2024, to discuss its second quarter financial results.</li>
<li>Benzinga Pro's charting tool helped identify the <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1">trend in HUN's stock</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="693" height="745" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052250/Screenshot-2024-07-18-at-2.52.45-PM.png" alt="" class="wp-image-442561" style="width:479px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052250/Screenshot-2024-07-18-at-2.52.45-PM.png 693w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052250/Screenshot-2024-07-18-at-2.52.45-PM-279x300.png 279w" sizes="(max-width: 693px) 100vw, 693px" /></a></figure>
<h3 class="wp-block-heading">The Scotts Miracle-Gro Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>)</h3>
<ul>
<li>Dividend Yield: 3.93%</li>
<li>JP Morgan analyst Jeffrey Zekauskasmaintained an Overweight rating and raised the price target from $70 to $85 on April 5. This analyst has an accuracy rate of 70%.</li>
<li>Raymond James analyst Joseph Altobello downgraded the stock from Strong Buy to Market Perform on March 25. This analyst has an accuracy rate of 70%.</li>
<li>Recent News: On June 6, ScottsMiracle-Gro said it now sees non-GAAP adjusted EBITDA of $530 million to $540 million versus earlier outlook of $575 million.</li>
<li>Benzinga Pro's earnings calendar was used to monitor <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1">SMG's upcoming earnings</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="647" height="740" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052412/Screenshot-2024-07-18-at-2.54.05-PM.png" alt="" class="wp-image-442562" style="width:414px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052412/Screenshot-2024-07-18-at-2.54.05-PM.png 647w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052412/Screenshot-2024-07-18-at-2.54.05-PM-262x300.png 262w" sizes="(max-width: 647px) 100vw, 647px" /></a></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39814553/jim-cramer-says-dont-sell-match-group-youve-just-got-a-very-very-smart-investor-in-there">Jim Cramer Says Don&#8217;t Sell Match Group: &#8216;You&#8217;ve Just Got A Very, Very Smart Investor In There</a>&#8216;</li>
</ul>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>

News

Dividends

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields

M&T Bank shares are trading higher after the company reported better-than-expected Q2 financial results.

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 50 points on Thursday.
Shares of Leslie&#8217;s, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) fell sharply in today's pre-market trading after the company issued preliminary third-quarter financial results below estimates and <a href="https://www.benzinga.com/news/earnings/24/07/39826675/leslies-stock-is-underwater-after-hours-diving-into-the-details">cut its FY24 guidance</a>.
After the market close on Wednesday, Leslie's announced it now expects third-quarter revenue of approximately $570 million versus estimates of $615.407 million. The pool supply company anticipates third-quarter adjusted earnings of 32 cents to 33 cents per share versus <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> estimates of 42 cents per share.
Leslie's also cut its full-year 2024 revenue guidance from a range of $1.141 billion to $1.47 billion to a new range of $1321 billion to $1.347 billion. The company slashed its adjusted earnings forecast from a range of 25 cents to 33 cents per share to a new range of 3 cents to 9 cents per share.
Leslie&#8217;s shares dipped 22.6% to $3.16 in the pre-market trading session.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Beyond Meat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>) shares fell 11.7% to $6.33 in pre-market trading following a report suggesting the company&#8217;s liquidity has weakened and it is engaging bondholders for debt discussions.</li>
<li>Domino&#8217;s Pizza, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) shares declined 9.1% to $430.00 in pre-market trading after the company reported mixed second-quarter results.</li>
<li>Stardust Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) shares fell 8.1% to $22.50 in pre-market trading after jumping around 145% on Wednesday.</li>
<li>ADMA Biologics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NASDAQ">ADMA</a>) shares declined 7.1% to $12.35 in pre-market trading following a 3% drop in the previous session.</li>
<li>Foot Locker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) shares declined 5.3% to $25.04 in pre-market trading. Morgan Stanley analyst Alex Straton downgraded Foot Locker from Equal-Weight to Underweight and lowered the price target from $24 to $18.</li>
<li>Nokia Oyj (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) fell 5.1% to $3.70 in pre-market trading following second-quarter results.</li>
<li>agilon health, inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) shares fell 4.8% to $7.02 in pre-market trading. agilon health recently appointed Karthik Rao, M.D., as Chief Medical Officer.</li>
<li>SunPower Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) shares slipped 4.4% to $2.41 in pre-market trading after falling over 6% on Wednesday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39814553/jim-cramer-says-dont-sell-match-group-youve-just-got-a-very-very-smart-investor-in-there">Jim Cramer Says Don&#8217;t Sell Match Group: &#8216;You&#8217;ve Just Got A Very, Very Smart Investor In There</a>&#8216;</li>
</ul>

Movers

ADMA

BYND

LESL

SDST

SPWR

Leslie's Issues Preliminary Financial Results, Joins Beyond Meat, Domino's And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Barclays analyst Lauren Lieberman downgrades Molson Coors Beverage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) from Equal-Weight to Underweight and lowers the price target from $55 to $47.

Downgrades

Barclays Downgrades Molson Coors Beverage to Underweight, Lowers Price Target to $47

<ul>
<li>Ford adds a third North American assembly plant to meet Ford Pro customer demand for one of its most popular and profitable vehicles; adding initial capacity for 100,000 F-Series Super Duty trucks, including future multi-energy technology, at Oakville Assembly Complex in Ontario, Canada</li>
<li>The move supports the Ford+ plan for profitable growth, including maximizing Ford's manufacturing footprint, extending global truck leadership and expanding its Ford Pro commercial business</li>
<li>Ford will make efficient investments to expand Super Duty production, initially securing approximately 1,800 jobs at Oakville Assembly Complex and adding about 150 jobs at Windsor Engine Complex, while adding roughly 70 jobs and additional overtime at U.S. component plants</li>
<li>Ford remains committed to developing a growing and profitable electric vehicle business, including three-row electric utility vehicles, leveraging its experience as a leader in U.S. three-row utilities and America's No. 2 electric vehicle brand</li>
</ul>
Ford Motor Company today announced plans to assemble F-Series Super Duty pickups at its Oakville Assembly Complex in Ontario, Canada, starting in 2026, boosting production of one of the company's most popular and profitable vehicles.
The move to add production of up to 100,000 units of its best-selling Super Duty to Oakville expands Super Duty production across three plants in North America, including Kentucky Truck Plant and Ohio Assembly Plant, which are operating at full capacity. It also paves the way to bring multi-energy technology to the next generation of Super Duty trucks, giving customers more freedom of choice and supporting Ford's electrification plans.

Contracts

Global

Ford Pro Demand Drives F-Series Super Duty Production Expansion To Canada, Plans To Invest ~$3B To Expand Super Duty Production

Novartis shares are trading lower. The company reported Q2 financial results.

Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) shares rose moderately in Thursday&#8217;s <a href="https://www.benzinga.com/premarket">premarket trading, </a>reversing some of the 1.57% decline seen in the previous session. 
The rebound came amid a general improvement in risk sentiment toward tech stocks after Wednesday&#8217;s drubbing. Wedbush analyst Daniel Ives, a Palantir bull, on Thursday announced a new bull-case price target of $50 for the stock. The analyst maintained an Outperform rating and a $35 price target.
Palantir has been a major focus over the past year, with expanding use cases for its marquee products leading to a large partner ecosystem, said Ives in the note. He noted that demand has been rising rapidly across both commercial and government organizations.
&#8220;With AI spending taking up more spending in IT budgets as more organizations learn how to properly implement this tech, <a href="https://www.benzinga.com/markets/equities/24/05/39104004/palantir-is-the-messi-of-artificial-intelligence-says-dan-ives-most-underestimated-ai-play">we believe the Messi of AI Palantir is in a prime spot </a>to continue expanding its pipeline as the company provides more use cases,&#8221; he said, adding that the Palantir story &#8220;remains very undervalued and misunderstood by the Street.&#8221;
Palantir is scheduled to report its second-quarter results after the market closes on Aug. 5. Analysts, on average, expect the company to report earnings of 8 cents per share, up from the year-ago&#8217;s 5 cents per share, and revenue of $652.14, representing an estimated 22.4% growth.
In premarket trading, Palantir rose 0.57% to $28.38, according to <a href="https://benzinga.grsm.io/register174">Benzinga Pro data. </a>The stock is up over 64% year-to-date.
See Also: <a href="https://www.benzinga.com/money/best-artificial-intelligence-stocks">Best Artificial Intelligence Stocks</a>
Photo via Shutterstock

Analyst Color

Equities

Reiteration

PLTR

Palantir Stock Up Over 60% This Year, But Analyst Says The Story Remains 'Very Undervalued And Misunderstood By The Street'

Syntec Optics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPTX#NASDAQ">OPTX</a>), a leading provider of scientific, technical instruments, aerospace, and defense optics, announced today that it has secured over $2.2 million in orders for its ultra-high-precision space optics. The company will utilize its newly developed dedicated production cell to scale production for deliveries scheduled for the third quarter of 2024.

OPTX

Syntec Optics Secures $2.2M In New Orders For Space Optics

Armlogi Holding Corp. ("Armlogi" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOC#NASDAQ">BTOC</a>), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment, today announced the substantial expansion of its trucking department through increased staffing, enhanced equipment, and extended services. This strategic expansion aims to double the trucking volume and extend specialized services to major clients, including Amazon, to address the growing demands of the e-sports logistics industry and other key market sectors.
Since 2023, Armlogi has observed significant trends in logistics that prompted a broadening of its service offerings. The Company has increased its port delivery capabilities and enhanced long- and short-distance logistics services to improve delivery timeliness, professionalism, and customization. This response to customer needs has led to doubling its customer base compared to the same period last year, with many new clients being prominent players in the e-sports logistics field.

BTOC

Armlogi Expands Trucking Operations To Meet Growing Customer Demand

JP Morgan analyst Rachel Vatnsdal downgrades 10x Genomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>) from Overweight to Neutral and lowers the price target from $40 to $20.

JP Morgan Downgrades 10x Genomics to Neutral, Lowers Price Target to $20

RBC Capital analyst Jon Arfstrom maintains Ally Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>) with a Outperform and raises the price target from $46 to $49.

ALLY

RBC Capital Maintains Outperform on Ally Financial, Raises Price Target to $49

Bell to expand use of the ServiceNow platform to augment tech services portfolio for Bell Business Markets enterprise customers as well as transform its network and IT infrastructure
Now Platform to streamline business-critical areas for Bell, including Network, Customer, Field Service Operations, and Corporate Services
MONTRÉAL&nbsp;and&nbsp;SANTA&nbsp;CLARA, Calif., July 18, 2024 /CNW/ -&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4214431-1&amp;h=517228798&amp;u=https%3A%2F%2Fwww.bell.ca%2F&amp;a=Bell+Canada">Bell Canada</a>, Canada's communications, tech services and digital media leader, and&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4214431-1&amp;h=3119280436&amp;u=http%3A%2F%2Fwww.servicenow.com%2F&amp;a=ServiceNow">ServiceNow</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>), the AI platform for business transformation, today announced&nbsp;a multi-year strategic agreement to accelerate Bell's transformation to meet the growing customer demand for tech services and digital media. The renewed commitment makes Bell one of ServiceNow's largest communications customers with a first of its kind collaboration in Canada.&nbsp;Bell will expand its use of the ServiceNow platform, supporting its own digital transformation while continuing to offer ServiceNow implementation expertise to support the digital transformation of its Bell Business Markets customers.

Bell Canada And ServiceNow Announce Expanded Multi-Year Strategic Agreement, Supporting Its Own Digital Transformation While Continuing To Offer ServiceNow Implementation Expertise To Support The Digital Transformation Of Its Bell Business Markets Customers

Evolv Becomes A Part of Guest Experience Improvements at Windy City Landmark
Evolv Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVLV#NASDAQ">EVLV</a>), a leading security technology company pioneering AI-based screening to create safer experiences, today announced its partnership with 360 CHICAGO, the observation deck and immersive experience on the 94th floor of 875 N Michigan Avenue, formerly the John Hancock Center in Chicago, Illinois.
360 CHICAGO uses an <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.evolvtechnology.com%2Fproducts%2Fevolv-express&amp;esheet=54095938&amp;newsitemid=20240718546656&amp;lan=en-US&amp;anchor=Evolv+Express&amp;index=1&amp;md5=25335a8bd966037216ae9d4723b8ee0d">Evolv Express</a>&#xAE; system to screen guests before they take the elevator up to the experience, which includes the TILT thrill ride and CloudBar, a cocktail lounge with panoramic views of the city. The system was installed in August 2023 after venue officials saw Evolv screening fans attending a local sporting event. 360 CHICAGO used to conduct manual bag checks at entry. When it recently underwent renovations, it included Evolv in a number of upgrades.

EVLV

Evolv Technology Elevates 360 CHICAGO Experience, Evolv Becomes A Part Of Guest Experience Improvements At Windy City Landmark

Truist Securities analyst Barry Jonas maintains Light &amp; Wonder (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNW#NASDAQ">LNW</a>) with a Buy and raises the price target from $115 to $120.

Truist Securities Maintains Buy on Light & Wonder, Raises Price Target to $120

Macro Economic Events

Macro Notification

Economics

General

ECB Leaves Rates Unchanged

Pure Biologics' exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.twistbioscience.com%2F&amp;esheet=54096019&amp;newsitemid=20240718647518&amp;lan=en-US&amp;anchor=Twist+Bioscience+Corporation&amp;index=1&amp;md5=a8252773dd773dfe5623b7bd1012baf5">Twist Bioscience Corporation</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that the first patient has been dosed in Pure Biologics' exploratory Phase 0 clinical study of PBA-0405. PBA-0405 is a fully human IgG1 antibody that was discovered using Twist Biopharma Solutions' synthetic antibody phage display libraries. Twist Biopharma Solutions, a division of Twist Bioscience, provides an integrated offering of in vitro, in vivo, and in silico tools for antibody discovery research. This exploratory study is designed to provide early insights into the biological effects of PBA-0405 within the tumor environment.

Biotech

TWST

Twist Bioscience Announces Clinical Progression Of Pure Biologics' Antibody Candidate Discovered Using Twist's Antibody Libraries

TD Cowen analyst Gregory Williams maintains Crown Castle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCI#NYSE">CCI</a>) with a Buy and raises the price target from $124 to $127.

TD Cowen Maintains Buy on Crown Castle, Raises Price Target to $127

Truist Securities analyst Barry Jonas maintains Golden Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDEN#NASDAQ">GDEN</a>) with a Buy and lowers the price target from $43 to $40.

GDEN

Truist Securities Maintains Buy on Golden Entertainment, Lowers Price Target to $40

Airbnb

Atour Lifestyle Holdings Limited - American Depositary Shares

Atour Lifestyle Holdings

Booking Holdings

Choice Hotels International, Inc. Common Stock

Choice Hotels Intl

Despegar.com

Expedia Group

Global Business Travel Group, Inc. Class A Common Stock

Global Business Travel

GreenTree Hospitality Group Ltd. American depositary shares, each representing one Class A ordinary share

GreenTree Hospitality Gr

Hyatt Hotels Corporation Class A Common Stock

Hyatt Hotels

Hilton Grand Vacations

Hilton Worldwide Holdings Inc. Common Stock

Hilton Worldwide Holdings

H World Group Limited - American Depositary Shares

H World Group

Intercontinental Hotels Group American Depositary Shares (Each representing one Ordinary Share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Sonder Holdings

News

Latest news for Sonder Holdings (NASDAQ:SONDW) Stock

People Also Watch